DNA abnormalities could up cancer risk in diabetics
Researchers have found that a type of genetic abnormality that has been associated to cancer is more common in people suffering from type 2 diabetes.
People with type 2 diabetes are already known to have a higher risk of cancers, especially blood cancers like lymphoma and leukaemia.
The new study, led by scientists at Imperial College London and CNRS in France, suggests that mutations called clonal mosaic events (CMEs) may partly explain why this is.
CMEs are defects that result in some cells having extra copies or missing copies of large chunks of DNA.